For millions of retirees, Medicare Part D is more than just insurance—it is the safeguard that keeps prescription medications affordable. But beginning in 2026, that safeguard may come at a steeper price.
Health policy experts warn that Part D premiums could rise by as much as $50 per month. Several factors are driving this increase: the growing use of high-cost new drugs, reductions in federal subsidies, and provisions within the Inflation Reduction Act that shift more financial responsibility to insurers.
Why Drug Costs Keep Climbing
According to the American Journal of Health-System Pharmacy, U.S. prescription drug spending surged by more than 10% in 2024. Interestingly, this increase was not driven by higher prices—many drugs saw slight price reductions. Instead, the primary driver was demand.
New treatments for autoimmune diseases, diabetes, and other chronic conditions are now widely available, and patients—particularly older adults—are turning to them in growing numbers.
For Medicare beneficiaries, these drugs can be life-changing. For insurers, however, they represent a substantial expense—costs that inevitably flow back to seniors in the form of higher premiums.
The Weight-Loss Drug Factor
Drugs like Wegovy and Ozempic are adding new complexity to Medicare’s financial picture. While Medicare does not cover medications prescribed solely for weight loss, many of these drugs are also approved for diabetes, one of the most common conditions among retirees.
As off-label use expands, insurers face escalating costs. And if the pilot program reportedly under consideration by the Trump administration moves forward—expanding Medicare coverage of these treatments as early as 2027—those costs could rise even further.
A Win for Patients, a Challenge for Insurers
This year, the Inflation Reduction Act delivered a major benefit to patients: a $2,000 annual cap on out-of-pocket prescription drug costs. For some retirees who previously spent over $10,000 annually on a single medication, this change is nothing short of transformative.
But while patients are shielded, insurers now bear the remaining costs once that cap is reached. As Stacie Dusetzina, professor of health policy at Vanderbilt University Medical Center, explains:
“The Inflation Reduction Act was necessary to make Part D proper health insurance, but there’s a cost to do so.”
Shrinking Federal Support
In 2025, the Biden administration introduced a $6 billion stabilization fund to help offset these pressures, temporarily lowering average premiums. But beginning in 2026, the Trump administration plans to cut this support by 40%. Without that financial cushion, insurers are expected to pass costs directly to enrollees.
What Seniors Should Do Now
The most important takeaway for Medicare beneficiaries is this: do not assume your current plan will remain the best option. With open enrollment beginning October 15, reviewing your coverage is critical.
Drug formularies, premiums, and out-of-pocket expenses shift each year. Failing to compare plans could mean hundreds—or even thousands—of dollars in avoidable costs.
As Dusetzina emphasizes:
“Everyone should shop plans in open enrollment. The plans change every year—and so do people’s medical needs.”
✅ Bottom line: Premium hikes are on the horizon, but seniors can protect themselves by staying proactive. Carefully evaluate your Medicare Part D options this fall to ensure you have the most cost-effective coverage for 2026 and beyond.